Hospira Recalls Heparin Sodium Injection Due to Human Hair Particulate
Hospira is recalling 63,378 units of Heparin Sodium injection because human hair was found sealed inside the container's administration port.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.
Plain-English summary
Hospira Inc. is recalling 63,378 flexible container units of Heparin Sodium, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection. The recall affects Lot # 41-046-JT, which has an expiration date of 11/01/2015. The product is distributed nationwide and is available by prescription only.
The recall was initiated due to the presence of particulate matter. Specifically, a particulate confirmed as human hair was found sealed between the tube and film at the round seal of the unused administration port of the container.
Healthcare providers and patients should discontinue use of the affected lots and contact Hospira for further instructions or replacement.
The recalled product
- Product
- HEPARIN SODIUM (HEPARIN SODIUM)
- Brand
- HEPARIN SODIUM
- Manufacturer
- Hospira Inc.
- Category
- Drug — Prescription Injectable
- Affected units
- 63,378
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 41-046-JT
- Exp 11/01/2015
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · HEPARIN SODIUM
- ModerateHeparin Sodium Injection Recalled Due to Labeling Issue
FDA (Drugs) · 2023-03-15
- HighHeparin Sodium injectable bags recalled due to potential sterility assurance issues
FDA (Drugs) · 2023-01-11
- SevereFresenius Kabi Recalls Heparin Sodium Injection Due to Subpotency
FDA (Drugs) · 2014-03-12
- SevereHospira Recalls Heparin Sodium Bags Due to Sterility Concerns
FDA (Drugs) · 2014-02-05
Same manufacturer · Hospira Inc.
See all →- CriticalHospira Recalls Dextrose Injection Syringes Due to Human Hair Particulate
FDA (Drugs) · 2017-05-31
- ModerateHospira Recalls Minibore Extension Sets Due to Solvent Occlusion
FDA (Devices) · 2017-01-18
- LowHospira Recalls Lidocaine and Dextrose Injection for Stability Failures
FDA (Drugs) · 2016-12-14
- SevereHospira Recalls Fentanyl Citrate Injection Ampules Due to Broken Tips
FDA (Drugs) · 2016-11-30
- HighHospira Symbiq Infusion Pump Recall for White Screen Safety Shutdown
FDA (Devices) · 2016-11-16
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02